Protecting Generations of Innovations


An internationally known and trusted name in IP Law

Maier & Maier was established with the goal of providing intellectual property analysis and advice for large, multi-national corporations, universities, middle-market and emerging market companies, and startups and spinouts. We are proud of our ability to advise our clients, and to obtain patent protection for a wide scale of technologies, and offer years of experience in litigation, licensing, and other intellectual property-related issues.

The History of Our Firm

Supreme Court Not Buying Helsinn On-Sale Argument

On Tuesday, December 4, the Supreme Court heard oral arguments in Helsinn Healthcare v. Teva Pharmaceuticals centered around the meaning of the phrase “On-Sale” under the AIA and whether the term was changed from the previous meaning. Helsinn originally sued Teva for infringement of four patents relating to palonosetron dosages in chemotherapy treatments in the […]

Read More »

PTAB Petitions Spike As BRI Era Closes

On October 10, 2018, the USPTO announced it would adopt the Phillips claim construction standard as of November 13, 2018. That means that as of yesterday, any petitions filed are no longer reviewed under the Broadest Reasonable Interpretation (BRI) standard that the PTAB had applied since its creation under the AIA. Instead, they will be […]

Read More »

USPTO Extends AFCP 2.0 Until September 30, 2019

The U.S. Patent Office announced that the After-Final Consideration Pilot 2.0 (AFCP 2.0) will be extended another year. Originally implemented in May 2013, the program allows for amendments and responses for the examiner’s consideration to be submitted after a Final Office Action has been sent. Prior to the implementation, applicants were limited to filing appeals […]

Read More »